The Effect of Enalapril and Carvedilol on Left Ventricular Dysfunction in Middle Childhood and Adolescent Patients With Muscular Dystrophy
![]() |
Kwon, Hye-Won
(Department of Pediatrics, Seoul National University Children's Hospital)
Kwon, Bo-Sang (Department of Pediatrics, Seoul National University Children's Hospital) Kim, Gi-Beom (Department of Pediatrics, Seoul National University Children's Hospital) Chae, Jong-Hee (Department of Pediatrics, Seoul National University Children's Hospital) Park, June-Dong (Department of Pediatrics, Seoul National University Children's Hospital) Bae, Eun-Jung (Department of Pediatrics, Seoul National University Children's Hospital) Noh, Chung-Il (Department of Pediatrics, Seoul National University Children's Hospital) |
1 | Emery AE. The muscular dystrophies. Lancet 2002;359:687-95. DOI ScienceOn |
2 | Emery AE. Population frequencies of inherited neuromuscular diseases: a world survey. Neuromuscul Disord 1991;1:19-29. DOI ScienceOn |
3 | Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1-19. DOI ScienceOn |
4 | McNally EM. Duchenne muscular dystrophy: how bad is the heart? Heart 2008;94:976-7. DOI ScienceOn |
5 | Kaspar RW, Allen HD, Montanaro F. Current understanding and management of dilated cardiomyopathy in Duchenne and Becker muscular dystrophy. J Am Acad Nurse Pract 2009;21:241-9. DOI ScienceOn |
6 | Jefferies JL, Eidem BW, Belmont JW, et al. Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 2005;112:2799-804. DOI ScienceOn |
7 | Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Bécane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005; 45:855-7. DOI ScienceOn |
8 | Duboc D, Meune C, Pierre B, et al. Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up. Am Heart J 2007;154:596-602 DOI ScienceOn |
9 | Giglio V. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 2007;99:147-8. DOI ScienceOn |
10 | Saito T, Matsumura T, Miyai I, Nozaki S, Shinno S. Carvedilol effectiveness for left ventricular-insufficient patients with Duchenne muscular dystrophy. Rinsho Shinkeigaku 2001;41:691-4. |
11 | Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 2004;17:630-3. DOI ScienceOn |
12 | Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83. DOI ScienceOn |
13 | Garcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998; 32:865-75. DOI ScienceOn |
14 | Tei C, Ling LH, Hodge DO, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function: a study in normals and dilated cardiomyopathy. J Cardiol 1995;26:357-66. |
15 | Sohn DW, Chai IH, Lee DJ, et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J Am Coll Cardiol 1997;30:474-80. DOI ScienceOn |
16 | Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of method. Circulation 1977; 55:613-8. DOI ScienceOn |
17 | Lamparter S, Sun Y, Weber KT. Angiotensin II receptor blockade during gestation attenuates collagen formation in the developing rat heart. Cardiovasc Res 1999;43:165-72. DOI ScienceOn |
18 | Bernal J, Pitta SR, Thatai D. Role of the renin-angiotensin-aldosterone system in diastolic heart failure: potential for pharmacologic intervention. Am J Cardiovasc Drugs 2006;6:373-81. DOI ScienceOn |
19 | Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Studies of Left Ventricular Dysfunction (SOLVD). Circulation 1990;82:1724-9. DOI ScienceOn |
20 | Ramaciotti C, Heistein LC, Coursey M, et al. Left ventricular function and response to enalapril in patients with Duchenne muscular dystrophy during the second decade of life. Am J Cardiol 2006;98:825-7. DOI ScienceOn |
21 | Cha DH, Cha YS, Kook JH, et al. Clinical efficacy of carvedilol in patients with moderate to severe congestive heart failure. Korean Circ J 1998; 28:523-31. |
22 | Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr 2001;138: 505-11. DOI ScienceOn |
23 | Ishikawa Y, Bach JR, Minami R. Cardioprotection for Duchenne's muscular dystrophy. Am Heart J 1999;137:895-902. DOI ScienceOn |
24 | Kajimoto H, Ishigaki K, Okumura K, et al. Beta-blocker therapy for cardiac dysfunction in patients with muscular dystrophy. Circ J 2006;70: 991-4. DOI ScienceOn |
25 | Ogata H, Ishikawa Y, Ishikawa Y, Minami R. Beneficial effects of betablockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy. J Cardiol 2009;53:72-8. DOI ScienceOn |
26 | American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics 2005;116:1569-73. DOI ScienceOn |
27 | Bahler RC, Mohyuddin T, Finkelhor RS, Jacobs IB. Contribution of Doppler tissue imaging and myocardial performance index to assessment of left ventricular function in patients with Duchenne's muscular dystrophy. J Am Soc Echocardiogr 2005;18:666-73. DOI ScienceOn |
28 | Giatrakos N, Kinali M, Stephens D, Dawson D, Muntoni F, Nihoyannopoulos P. Cardiac tissue velocities and strain rate in the early detection of myocardial dysfunction of asymptomatic boys with Duchenne's muscular dystrophy: relationship to clinical outcome. Heart 2006;92:840-2. |
29 | Ogata H, Nakatani S, Ishikawa Y, et al. Myocardial strain changes in Duchenne muscular dystrophy without overt cardiomyopathy. Int J Cardiol 2007;115:190-5. DOI ScienceOn |
30 | Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 1997;96:509-16. DOI ScienceOn |
31 | Mori K, Manabe T, Nii M, Hayabuchi Y, Kuroda Y, Tatara K. Plasma levels of natriuretic peptide and echocardiographic parameters in patients with Duchenne's progressive muscular dystrophy. Pediatr Cardiol 2002; 23:160-6. DOI ScienceOn |
![]() |